NGM BIOPHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ngm Biopharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$2.1M -100% Dec 31, 2023 10-K 2024-03-11
Q3 2023 $538K -$2.06M -79.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.07M -$2.02M -65.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.59M -$1.98M -55.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.1M -$1.95M -48.2% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $2.6M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.09M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $3.57M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4.05M +$4.05M Dec 31, 2021 10-K 2023-02-28
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.